Monoclonal antibodies in cervical malignancy-related HPV

Monoclonal antibodies in cervical malignancy-related HPV

Despite many efforts to treat HPV infection, cervical cancer survival is still poor for several reasons, including resistance to chemotherapy and relapse. Numerous treatments such as surgery, radiation therapy, immune cell-based therapies, siRNA combined with various drugs, and immunotherapy are bei...

Full description

Bibliographic Details
Main Authors: Parisa Shiri Aghbash, Nima Hemmat, Hamidreza Fathi, Hossein Bannazadeh Baghi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
anti-EGFR
anti-VEGF
cervical neoplasm
immune checkpoint inhibitors
monoclonal antibody
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.904790/full

Similar Items

Similar Items